Ionic glutamate receptor antagonists, including: the N-methyl-D-aspartate receptor, the maricin receptor, and the alpha-amino-3-hydroxy-5 methyl-4 isoxazole receptor, which are coupled to ion channels to form receptor channel complexes that mediate fast signalling.

This report aims to provide a comprehensive study of the global market for Lonotropic Glutamate Receptor Antagonist. Report Highlights:

(1) Global Lonotropic Glutamate Receptor Antagonist market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Lonotropic Glutamate Receptor Antagonist market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(3) China Lonotropic Glutamate Receptor Antagonist market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(4) Global Lonotropic Glutamate Receptor Antagonist segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Lonotropic Glutamate Receptor Antagonist segment by type and by application and regional segment by type and by application.

(6) Global major production regions of Lonotropic Glutamate Receptor Antagonist, capacity, production and trends.

(7) Lonotropic Glutamate Receptor Antagonist industry supply chain, upstream, midstream and downstream analysis.

According to latest study, the global market for Lonotropic Glutamate Receptor Antagonist should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

China Lonotropic Glutamate Receptor Antagonist market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

The United States Lonotropic Glutamate Receptor Antagonist market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

In terms of type, N-Methyl-D-Aspartate Receptors segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospitals has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Lonotropic Glutamate Receptor Antagonist include Artemis Neuroscience, VistaGen Therapeutics, Rottapharm Madaus, Amorsa Therapeutics, Newron Pharmaceuticals, Purdue Biopharma, Relmada Therapeutics, BioCrea GmbH and Cerecor Inc., etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

N-Methyl-D-Aspartate Receptors

Marine Human Alginate Receptors

α-Amino-3 Hydroxy-5 Methyl-4 Isoxazole Receptors

Market segment by application, can be divided into

Hospitals

Clinics

Research Institutes

Others

Market segment by players, this report covers

Artemis Neuroscience

VistaGen Therapeutics

Rottapharm Madaus

Amorsa Therapeutics

Newron Pharmaceuticals

Purdue Biopharma

Relmada Therapeutics

BioCrea GmbH

Cerecor Inc.

NeurOp Inc.

UCB SA

Novartis AG

Luc Therapeutics Inc.

Evotec AG

1 Market Overview

1.1 Lonotropic Glutamate Receptor Antagonist Definition

1.2 Global Lonotropic Glutamate Receptor Antagonist Market Size and Forecast

1.2.1 By Revenue, Global Lonotropic Glutamate Receptor Antagonist Market Size, 2018-2029

1.2.2 By Sales Volume, Global Lonotropic Glutamate Receptor Antagonist Market Size, 2018-2029

1.2.3 Global Lonotropic Glutamate Receptor Antagonist Price Trend, 2018-2029

1.3 China Lonotropic Glutamate Receptor Antagonist Market Size and Forecast

1.3.1 By Revenue, China Lonotropic Glutamate Receptor Antagonist Market Size, 2018-2029

1.3.2 By Sales Volume, China Lonotropic Glutamate Receptor Antagonist Market Size, 2018-2029

1.3.3 China Lonotropic Glutamate Receptor Antagonist Price Trend, 2018-2029

1.4 China Percentage in Global Market

1.4.1 By Revenue, China Lonotropic Glutamate Receptor Antagonist Share in Global Market, 2018-2029

1.4.2 By Sales Volume, China Lonotropic Glutamate Receptor Antagonist Share in Global Market, 2018-2029

1.4.3 Lonotropic Glutamate Receptor Antagonist Market Size: China VS Global, 2018-2029

1.5 Lonotropic Glutamate Receptor Antagonist Market Dynamics

1.5.1 Lonotropic Glutamate Receptor Antagonist Market Drivers

1.5.2 Lonotropic Glutamate Receptor Antagonist Market Restraints

1.5.3 Lonotropic Glutamate Receptor Antagonist Industry Trends

1.5.4 Lonotropic Glutamate Receptor Antagonist Industry Policy

2 Global Competitive Landscape by Company

2.1 Global Lonotropic Glutamate Receptor Antagonist Revenue by Company, 2018-2023

2.2 Global Lonotropic Glutamate Receptor Antagonist Sales Volume by Company, 2018-2023

2.3 Global Lonotropic Glutamate Receptor Antagonist Price by Company, 2018-2023

2.4 Global Lonotropic Glutamate Receptor Antagonist Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.5 Global Lonotropic Glutamate Receptor Antagonist Concentration Ratio

2.6 Global Lonotropic Glutamate Receptor Antagonist Mergers & Acquisitions, Expansion Plans

2.7 Global Lonotropic Glutamate Receptor Antagonist Manufacturers Product Type

3 China Competitive Landscape by Company

3.1 China Lonotropic Glutamate Receptor Antagonist Revenue by Company, 2018-2023

3.2 China Lonotropic Glutamate Receptor Antagonist Sales Volume by Company, 2018-2023

3.3 China Lonotropic Glutamate Receptor Antagonist Lonotropic Glutamate Receptor Antagonist Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.4 China Lonotropic Glutamate Receptor Antagonist Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)

3.5 Chinese Local Players, Lonotropic Glutamate Receptor Antagonist Domestic VS Export

3.6 China Market, Lonotropic Glutamate Receptor Antagonist Import & Export

3.6.1 China Market, Lonotropic Glutamate Receptor Antagonist Import & Export, 2018-2029

3.6.2 China Lonotropic Glutamate Receptor Antagonist Import & Export Trends

3.6.3 Main Sources of China Lonotropic Glutamate Receptor Antagonist Import

3.6.4 Export Destination of China Lonotropic Glutamate Receptor Antagonist

4 Lonotropic Glutamate Receptor Antagonist Production by Region

4.1 Global Lonotropic Glutamate Receptor Antagonist Capacity, Production and Capacity Utilization, 2018-2029

4.2 Global Geographic Distribution of Lonotropic Glutamate Receptor Antagonist Manufacturers

4.3 Global Major Manufacturers, Lonotropic Glutamate Receptor Antagonist Capacity Expansion and Future Plans

4.4 Global Lonotropic Glutamate Receptor Antagonist Capacity by Region

4.5 Global Lonotropic Glutamate Receptor Antagonist Production by Region

4.5.1 Global Lonotropic Glutamate Receptor Antagonist Production & Forecast by Region, 2018 VS 2022 VS 2029

4.5.2 Global Lonotropic Glutamate Receptor Antagonist Production by Region, 2018-2023

4.5.3 Global Lonotropic Glutamate Receptor Antagonist Production Market Share & Forecast by Region, 2018-2029

5 Industry Chain Analysis

5.1 Lonotropic Glutamate Receptor Antagonist Industry Chain

5.2 Lonotropic Glutamate Receptor Antagonist Upstream Analysis

5.2.1 Lonotropic Glutamate Receptor Antagonist Core Raw Materials

5.2.2 Main Manufacturers of Lonotropic Glutamate Receptor Antagonist Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Lonotropic Glutamate Receptor Antagonist Production Mode

5.6 Lonotropic Glutamate Receptor Antagonist Procurement Model

5.7 Lonotropic Glutamate Receptor Antagonist Industry Sales Model and Sales Channels

5.7.1 Lonotropic Glutamate Receptor Antagonist Sales Model

5.7.2 Lonotropic Glutamate Receptor Antagonist Typical Distributors

6 Sights by Type

6.1 Lonotropic Glutamate Receptor Antagonist Classification

6.1.1 N-Methyl-D-Aspartate Receptors

6.1.2 Marine Human Alginate Receptors

6.1.3 α-Amino-3 Hydroxy-5 Methyl-4 Isoxazole Receptors

6.2 By Type, Global Lonotropic Glutamate Receptor Antagonist Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Type, Global Lonotropic Glutamate Receptor Antagonist Revenue, 2018-2029

6.4 By Type, Global Lonotropic Glutamate Receptor Antagonist Sales Volume, 2018-2029

6.5 By Type, Global Lonotropic Glutamate Receptor Antagonist Price, 2018-2029

7 Sights by Application

7.1 Lonotropic Glutamate Receptor Antagonist Segment by Application

7.1.1 Hospitals

7.1.2 Clinics

7.1.3 Research Institutes

7.1.4 Others

7.2 By Application, Global Lonotropic Glutamate Receptor Antagonist Market Size & CAGR, 2018 VS 2022 VS 2029

7.3 By Application, Global Lonotropic Glutamate Receptor Antagonist Revenue, 2018-2029

7.4 By Application, Global Lonotropic Glutamate Receptor Antagonist Sales Volume, 2018-2029

7.5 By Application, Global Lonotropic Glutamate Receptor Antagonist Price, 2018-2029

8 Sales Sights by Region

8.1 By Region, Global Lonotropic Glutamate Receptor Antagonist Market Size, 2018 VS 2022 VS 2029

8.2 By Region, Global Lonotropic Glutamate Receptor Antagonist Revenue, 2018-2029

8.3 By Region, Global Lonotropic Glutamate Receptor Antagonist Sales Volume, 2018-2029

8.4 North America

8.4.1 North America Lonotropic Glutamate Receptor Antagonist Market Size & Forecasts, 2018-2029

8.4.2 By Country, North America Lonotropic Glutamate Receptor Antagonist Market Size Market Share

8.5 Europe

8.5.1 Europe Lonotropic Glutamate Receptor Antagonist Market Size & Forecasts, 2018-2029

8.5.2 By Country, Europe Lonotropic Glutamate Receptor Antagonist Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Lonotropic Glutamate Receptor Antagonist Market Size & Forecasts, 2018-2029

8.6.2 By Country/Region, Asia Pacific Lonotropic Glutamate Receptor Antagonist Market Size Market Share

8.7 South America

8.7.1 South America Lonotropic Glutamate Receptor Antagonist Market Size & Forecasts, 2018-2029

8.7.2 By Country, South America Lonotropic Glutamate Receptor Antagonist Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Lonotropic Glutamate Receptor Antagonist Market Size & CAGR，2018 VS 2022 VS 2029

9.2 By Country, Global Lonotropic Glutamate Receptor Antagonist Revenue, 2018-2029

9.3 By Country, Global Lonotropic Glutamate Receptor Antagonist Sales Volume, 2018-2029

9.4 U.S.

9.4.1 U.S. Lonotropic Glutamate Receptor Antagonist Market Size, 2018-2029

9.4.2 By Company, U.S. Lonotropic Glutamate Receptor Antagonist Sales Volume Market Share, 2022

9.4.3 By Type, U.S. Lonotropic Glutamate Receptor Antagonist Market Size, Share, 2022 VS 2029

9.4.4 By Application, U.S. Lonotropic Glutamate Receptor Antagonist Market Size, Share, 2022 VS 2029

9.5 Europe

9.5.1 Europe Lonotropic Glutamate Receptor Antagonist Market Size, 2018-2029

9.5.2 By Company, Europe Lonotropic Glutamate Receptor Antagonist Sales Volume Market Share, 2022

9.5.3 By Type, Europe Lonotropic Glutamate Receptor Antagonist Market Size, Share, 2022 VS 2029

9.5.4 By Application, Europe Lonotropic Glutamate Receptor Antagonist Market Size, Share, 2022 VS 2029

9.6 China

9.6.1 China Lonotropic Glutamate Receptor Antagonist Market Size, 2018-2029

9.6.2 By Company, China Lonotropic Glutamate Receptor Antagonist Sales Volume Market Share, 2022

9.6.3 By Type, China Lonotropic Glutamate Receptor Antagonist Market Size, Share, 2022 VS 2029

9.6.4 By Application, China Lonotropic Glutamate Receptor Antagonist Market Size, Share, 2022 VS 2029

9.7 Japan

9.7.1 Japan Lonotropic Glutamate Receptor Antagonist Market Size, 2018-2029

9.7.2 By Company, Japan Lonotropic Glutamate Receptor Antagonist Sales Volume Market Share, 2022

9.7.3 By Type, Japan Lonotropic Glutamate Receptor Antagonist Market Size, Share, 2022 VS 2029

9.7.4 By Application, Japan Lonotropic Glutamate Receptor Antagonist Market Size, Share, 2022 VS 2029

9.8 South Korea

9.8.1 South Korea Lonotropic Glutamate Receptor Antagonist Market Size, 2018-2029

9.8.2 By Company, South Korea Lonotropic Glutamate Receptor Antagonist Sales Volume Market Share, 2022

9.8.3 By Type, South Korea Lonotropic Glutamate Receptor Antagonist Market Size, Share, 2022 VS 2029

9.8.4 By Application, South Korea Lonotropic Glutamate Receptor Antagonist Market Size, Share, 2022 VS 2029

9.9 Southeast Asia

9.9.1 Southeast Asia Lonotropic Glutamate Receptor Antagonist Market Size, 2018-2029

9.9.2 By Company, Southeast Asia Lonotropic Glutamate Receptor Antagonist Sales Volume Market Share, 2022

9.9.3 By Type, Southeast Asia Lonotropic Glutamate Receptor Antagonist Market Size, Share, 2022 VS 2029

9.9.4 By Application, Southeast Asia Lonotropic Glutamate Receptor Antagonist Market Size, Share, 2022 VS 2029

9.10 India

9.10.1 India Lonotropic Glutamate Receptor Antagonist Market Size, 2018-2029

9.10.2 By Company, India Lonotropic Glutamate Receptor Antagonist Sales Volume Market Share, 2022

9.10.3 By Type, India Lonotropic Glutamate Receptor Antagonist Market Size, Share, 2022 VS 2029

9.10.4 By Application, India Lonotropic Glutamate Receptor Antagonist Market Size, Share, 2022 VS 2029

9.11 Middle East & Asia

9.11.1 Middle East & Asia Lonotropic Glutamate Receptor Antagonist Market Size, 2018-2029

9.11.2 By Company, Middle East & Asia Lonotropic Glutamate Receptor Antagonist Sales Volume Market Share, 2022

9.11.3 By Type, Middle East & Asia Lonotropic Glutamate Receptor Antagonist Market Size, Share, 2022 VS 2029

9.11.4 By Application, Middle East & Asia Lonotropic Glutamate Receptor Antagonist Market Size, Share, 2022 VS 2029

10 Manufacturers Profile

10.1 Artemis Neuroscience

10.1.1 Artemis Neuroscience Company Information, Head Office, Market Area and Industry Position

10.1.2 Artemis Neuroscience Lonotropic Glutamate Receptor Antagonist Models, Specifications and Application

10.1.3 Artemis Neuroscience Lonotropic Glutamate Receptor Antagonist Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.1.4 Artemis Neuroscience Company Profile and Main Business

10.1.5 Artemis Neuroscience Recent Developments

10.2 VistaGen Therapeutics

10.2.1 VistaGen Therapeutics Company Information, Head Office, Market Area and Industry Position

10.2.2 VistaGen Therapeutics Lonotropic Glutamate Receptor Antagonist Models, Specifications and Application

10.2.3 VistaGen Therapeutics Lonotropic Glutamate Receptor Antagonist Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.2.4 VistaGen Therapeutics Company Profile and Main Business

10.2.5 VistaGen Therapeutics Recent Developments

10.3 Rottapharm Madaus

10.3.1 Rottapharm Madaus Company Information, Head Office, Market Area and Industry Position

10.3.2 Rottapharm Madaus Lonotropic Glutamate Receptor Antagonist Models, Specifications and Application

10.3.3 Rottapharm Madaus Lonotropic Glutamate Receptor Antagonist Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.3.4 Rottapharm Madaus Company Profile and Main Business

10.3.5 Rottapharm Madaus Recent Developments

10.4 Amorsa Therapeutics

10.4.1 Amorsa Therapeutics Company Information, Head Office, Market Area and Industry Position

10.4.2 Amorsa Therapeutics Lonotropic Glutamate Receptor Antagonist Models, Specifications and Application

10.4.3 Amorsa Therapeutics Lonotropic Glutamate Receptor Antagonist Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.4.4 Amorsa Therapeutics Company Profile and Main Business

10.4.5 Amorsa Therapeutics Recent Developments

10.5 Newron Pharmaceuticals

10.5.1 Newron Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

10.5.2 Newron Pharmaceuticals Lonotropic Glutamate Receptor Antagonist Models, Specifications and Application

10.5.3 Newron Pharmaceuticals Lonotropic Glutamate Receptor Antagonist Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.5.4 Newron Pharmaceuticals Company Profile and Main Business

10.5.5 Newron Pharmaceuticals Recent Developments

10.6 Purdue Biopharma

10.6.1 Purdue Biopharma Company Information, Head Office, Market Area and Industry Position

10.6.2 Purdue Biopharma Lonotropic Glutamate Receptor Antagonist Models, Specifications and Application

10.6.3 Purdue Biopharma Lonotropic Glutamate Receptor Antagonist Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.6.4 Purdue Biopharma Company Profile and Main Business

10.6.5 Purdue Biopharma Recent Developments

10.7 Relmada Therapeutics

10.7.1 Relmada Therapeutics Company Information, Head Office, Market Area and Industry Position

10.7.2 Relmada Therapeutics Lonotropic Glutamate Receptor Antagonist Models, Specifications and Application

10.7.3 Relmada Therapeutics Lonotropic Glutamate Receptor Antagonist Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.7.4 Relmada Therapeutics Company Profile and Main Business

10.7.5 Relmada Therapeutics Recent Developments

10.8 BioCrea GmbH

10.8.1 BioCrea GmbH Company Information, Head Office, Market Area and Industry Position

10.8.2 BioCrea GmbH Lonotropic Glutamate Receptor Antagonist Models, Specifications and Application

10.8.3 BioCrea GmbH Lonotropic Glutamate Receptor Antagonist Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.8.4 BioCrea GmbH Company Profile and Main Business

10.8.5 BioCrea GmbH Recent Developments

10.9 Cerecor Inc.

10.9.1 Cerecor Inc. Company Information, Head Office, Market Area and Industry Position

10.9.2 Cerecor Inc. Lonotropic Glutamate Receptor Antagonist Models, Specifications and Application

10.9.3 Cerecor Inc. Lonotropic Glutamate Receptor Antagonist Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.9.4 Cerecor Inc. Company Profile and Main Business

10.9.5 Cerecor Inc. Recent Developments

10.10 NeurOp Inc.

10.10.1 NeurOp Inc. Company Information, Head Office, Market Area and Industry Position

10.10.2 NeurOp Inc. Lonotropic Glutamate Receptor Antagonist Models, Specifications and Application

10.10.3 NeurOp Inc. Lonotropic Glutamate Receptor Antagonist Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.10.4 NeurOp Inc. Company Profile and Main Business

10.10.5 NeurOp Inc. Recent Developments

10.11 UCB SA

10.11.1 UCB SA Company Information, Head Office, Market Area and Industry Position

10.11.2 UCB SA Lonotropic Glutamate Receptor Antagonist Models, Specifications and Application

10.11.3 UCB SA Lonotropic Glutamate Receptor Antagonist Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.11.4 UCB SA Company Profile and Main Business

10.11.5 UCB SA Recent Developments

10.12 Novartis AG

10.12.1 Novartis AG Company Information, Head Office, Market Area and Industry Position

10.12.2 Novartis AG Lonotropic Glutamate Receptor Antagonist Models, Specifications and Application

10.12.3 Novartis AG Lonotropic Glutamate Receptor Antagonist Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.12.4 Novartis AG Company Profile and Main Business

10.12.5 Novartis AG Recent Developments

10.13 Luc Therapeutics Inc.

10.13.1 Luc Therapeutics Inc. Company Information, Head Office, Market Area and Industry Position

10.13.2 Luc Therapeutics Inc. Lonotropic Glutamate Receptor Antagonist Models, Specifications and Application

10.13.3 Luc Therapeutics Inc. Lonotropic Glutamate Receptor Antagonist Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.13.4 Luc Therapeutics Inc. Company Profile and Main Business

10.13.5 Luc Therapeutics Inc. Recent Developments

10.14 Evotec AG

10.14.1 Evotec AG Company Information, Head Office, Market Area and Industry Position

10.14.2 Evotec AG Lonotropic Glutamate Receptor Antagonist Models, Specifications and Application

10.14.3 Evotec AG Lonotropic Glutamate Receptor Antagonist Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.14.4 Evotec AG Company Profile and Main Business

10.14.5 Evotec AG Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Lonotropic Glutamate Receptor Antagonist Market Size & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Lonotropic Glutamate Receptor Antagonist Market Restraints

Table 3. Lonotropic Glutamate Receptor Antagonist Market Trends

Table 4. Lonotropic Glutamate Receptor Antagonist Industry Policy

Table 5. Global Lonotropic Glutamate Receptor Antagonist Revenue by Company, 2018-2023, US$ million

Table 6. Global Lonotropic Glutamate Receptor Antagonist Revenue Market Share by Company, 2018-2023

Table 7. Global Lonotropic Glutamate Receptor Antagonist Sales Volume by Company, 2018-2023, (Units)

Table 8. Global Lonotropic Glutamate Receptor Antagonist Sales Volume Market Share by Company, 2018-2023

Table 9. Global Lonotropic Glutamate Receptor Antagonist Price by Company, 2018-2023, (US$/Unit)

Table 10. Global Lonotropic Glutamate Receptor Antagonist Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Lonotropic Glutamate Receptor Antagonist Mergers & Acquisitions, Expansion Plans

Table 12. Global Lonotropic Glutamate Receptor Antagonist Manufacturers Product Type

Table 13. China Lonotropic Glutamate Receptor Antagonist Revenue by Company, 2018-2023, US$ million

Table 14. China Lonotropic Glutamate Receptor Antagonist Revenue Market Share by Company, 2018-2023

Table 15. China Lonotropic Glutamate Receptor Antagonist Sales Volume by Company, 2018-2023, (Units)

Table 16. China Lonotropic Glutamate Receptor Antagonist Sales Volume Market Share by Company, 2018-2023

Table 17. China Market, Lonotropic Glutamate Receptor Antagonist Production, Sales, Import and Export, 2018-2029, (Units)

Table 18. China Lonotropic Glutamate Receptor Antagonist Import & Export Trends

Table 19. Main Sources of China Lonotropic Glutamate Receptor Antagonist Import

Table 20. Export Destination of China Lonotropic Glutamate Receptor Antagonist

Table 21. Global Headquarters and Manufacturing Base of Lonotropic Glutamate Receptor Antagonist Manufacturers

Table 22. Global Major Manufacturers, Lonotropic Glutamate Receptor Antagonist Capacity Expansion and Future Plans

Table 23. Global Lonotropic Glutamate Receptor Antagonist Production & Forecast by Region, 2018 VS 2022 VS 2029, (Units)

Table 24. Global Lonotropic Glutamate Receptor Antagonist Production by Region, 2018-2023, (Units)

Table 25. Global Lonotropic Glutamate Receptor Antagonist Production Forecast by Region, 2023-2029, (Units)

Table 26. Global Key Players of Lonotropic Glutamate Receptor Antagonist Upstream (Raw Materials)

Table 27. Global Lonotropic Glutamate Receptor Antagonist Typical Customers

Table 28. Lonotropic Glutamate Receptor Antagonist Typical Distributors

Table 29. By Type, Global Lonotropic Glutamate Receptor Antagonist Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Application, Global Lonotropic Glutamate Receptor Antagonist Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 31. By Region, Global Lonotropic Glutamate Receptor Antagonist Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 32. By Region, Global Lonotropic Glutamate Receptor Antagonist Revenue, 2018-2029, US$ Million

Table 33. By Region, Global Lonotropic Glutamate Receptor Antagonist Sales Volume, 2018-2029, (Units)

Table 34. By Country, Global Lonotropic Glutamate Receptor Antagonist Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 35. By Country, Global Lonotropic Glutamate Receptor Antagonist Revenue, 2018-2029, US$ Million

Table 36. By Country, Global Lonotropic Glutamate Receptor Antagonist Revenue Market Share, 2018-2029

Table 37. By Country, Global Lonotropic Glutamate Receptor Antagonist Sales Volume, 2018-2029, (Units)

Table 38. By Country, Global Lonotropic Glutamate Receptor Antagonist Sales Volume Market Share, 2018-2029

Table 39. Artemis Neuroscience Company Information, Head Office, Market Area and Industry Position

Table 40. Artemis Neuroscience Lonotropic Glutamate Receptor Antagonist Models, Specifications and Application

Table 41. Artemis Neuroscience Lonotropic Glutamate Receptor Antagonist Sales Volume (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 42. Artemis Neuroscience Company Profile and Main Business

Table 43. Artemis Neuroscience Recent Developments

Table 44. VistaGen Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 45. VistaGen Therapeutics Lonotropic Glutamate Receptor Antagonist Models, Specifications and Application

Table 46. VistaGen Therapeutics Lonotropic Glutamate Receptor Antagonist Sales Volume (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 47. VistaGen Therapeutics Company Profile and Main Business

Table 48. VistaGen Therapeutics Recent Developments

Table 49. Rottapharm Madaus Company Information, Head Office, Market Area and Industry Position

Table 50. Rottapharm Madaus Lonotropic Glutamate Receptor Antagonist Models, Specifications and Application

Table 51. Rottapharm Madaus Lonotropic Glutamate Receptor Antagonist Sales Volume (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 52. Rottapharm Madaus Company Profile and Main Business

Table 53. Rottapharm Madaus Recent Developments

Table 54. Amorsa Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 55. Amorsa Therapeutics Lonotropic Glutamate Receptor Antagonist Models, Specifications and Application

Table 56. Amorsa Therapeutics Lonotropic Glutamate Receptor Antagonist Sales Volume (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 57. Amorsa Therapeutics Company Profile and Main Business

Table 58. Amorsa Therapeutics Recent Developments

Table 59. Newron Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 60. Newron Pharmaceuticals Lonotropic Glutamate Receptor Antagonist Models, Specifications and Application

Table 61. Newron Pharmaceuticals Lonotropic Glutamate Receptor Antagonist Sales Volume (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 62. Newron Pharmaceuticals Company Profile and Main Business

Table 63. Newron Pharmaceuticals Recent Developments

Table 64. Purdue Biopharma Company Information, Head Office, Market Area and Industry Position

Table 65. Purdue Biopharma Lonotropic Glutamate Receptor Antagonist Models, Specifications and Application

Table 66. Purdue Biopharma Lonotropic Glutamate Receptor Antagonist Sales Volume (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 67. Purdue Biopharma Company Profile and Main Business

Table 68. Purdue Biopharma Recent Developments

Table 69. Relmada Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 70. Relmada Therapeutics Lonotropic Glutamate Receptor Antagonist Models, Specifications and Application

Table 71. Relmada Therapeutics Lonotropic Glutamate Receptor Antagonist Sales Volume (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 72. Relmada Therapeutics Company Profile and Main Business

Table 73. Relmada Therapeutics Recent Developments

Table 74. BioCrea GmbH Company Information, Head Office, Market Area and Industry Position

Table 75. BioCrea GmbH Lonotropic Glutamate Receptor Antagonist Models, Specifications and Application

Table 76. BioCrea GmbH Lonotropic Glutamate Receptor Antagonist Sales Volume (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 77. BioCrea GmbH Company Profile and Main Business

Table 78. BioCrea GmbH Recent Developments

Table 79. Cerecor Inc. Company Information, Head Office, Market Area and Industry Position

Table 80. Cerecor Inc. Lonotropic Glutamate Receptor Antagonist Models, Specifications and Application

Table 81. Cerecor Inc. Lonotropic Glutamate Receptor Antagonist Sales Volume (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 82. Cerecor Inc. Company Profile and Main Business

Table 83. Cerecor Inc. Recent Developments

Table 84. NeurOp Inc. Company Information, Head Office, Market Area and Industry Position

Table 85. NeurOp Inc. Lonotropic Glutamate Receptor Antagonist Models, Specifications and Application

Table 86. NeurOp Inc. Lonotropic Glutamate Receptor Antagonist Sales Volume (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 87. NeurOp Inc. Company Profile and Main Business

Table 88. NeurOp Inc. Recent Developments

Table 89. UCB SA Company Information, Head Office, Market Area and Industry Position

Table 90. UCB SA Lonotropic Glutamate Receptor Antagonist Models, Specifications and Application

Table 91. UCB SA Lonotropic Glutamate Receptor Antagonist Sales Volume (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 92. UCB SA Company Profile and Main Business

Table 93. UCB SA Recent Developments

Table 94. Novartis AG Company Information, Head Office, Market Area and Industry Position

Table 95. Novartis AG Lonotropic Glutamate Receptor Antagonist Models, Specifications and Application

Table 96. Novartis AG Lonotropic Glutamate Receptor Antagonist Sales Volume (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 97. Novartis AG Company Profile and Main Business

Table 98. Novartis AG Recent Developments

Table 99. Luc Therapeutics Inc. Company Information, Head Office, Market Area and Industry Position

Table 100. Luc Therapeutics Inc. Lonotropic Glutamate Receptor Antagonist Models, Specifications and Application

Table 101. Luc Therapeutics Inc. Lonotropic Glutamate Receptor Antagonist Sales Volume (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 102. Luc Therapeutics Inc. Company Profile and Main Business

Table 103. Luc Therapeutics Inc. Recent Developments

Table 104. Evotec AG Company Information, Head Office, Market Area and Industry Position

Table 105. Evotec AG Lonotropic Glutamate Receptor Antagonist Models, Specifications and Application

Table 106. Evotec AG Lonotropic Glutamate Receptor Antagonist Sales Volume (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 107. Evotec AG Company Profile and Main Business

Table 108. Evotec AG Recent Developments

List of Figure

Figure 1. Lonotropic Glutamate Receptor Antagonist Picture

Figure 2. By Revenue, Global Lonotropic Glutamate Receptor Antagonist Market Size and Forecast, 2018-2029, US$ Million

Figure 3. By Sales Volume, Global Lonotropic Glutamate Receptor Antagonist Market Size and Forecast, 2018-2029, (Units)

Figure 4. Global Lonotropic Glutamate Receptor Antagonist Price Trend, 2018-2029, (US$/Unit)

Figure 5. By Revenue, China Lonotropic Glutamate Receptor Antagonist Market Size and Forecast, 2018-2029, US$ million

Figure 6. By Sales Volume, China Lonotropic Glutamate Receptor Antagonist Market Size and Forecast, 2018-2029, (Units)

Figure 7. China Lonotropic Glutamate Receptor Antagonist Price Trend, 2018-2029 (US$/Unit)

Figure 8. By Revenue, China Lonotropic Glutamate Receptor Antagonist Share of Global Market, 2018-2029

Figure 9. By Sales Volume, China Lonotropic Glutamate Receptor Antagonist Share of Global Market, 2018-2029

Figure 10. Global Lonotropic Glutamate Receptor Antagonist Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global Lonotropic Glutamate Receptor Antagonist Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China Lonotropic Glutamate Receptor Antagonist Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China Lonotropic Glutamate Receptor Antagonist Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China Lonotropic Glutamate Receptor Antagonist Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 15. Chinese Local Players, Proportion of Lonotropic Glutamate Receptor Antagonist Domestic VS Export, 2022

Figure 16. Global Lonotropic Glutamate Receptor Antagonist Capacity, Production and Capacity Utilization, 2018-2029

Figure 17. Global Lonotropic Glutamate Receptor Antagonist Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global Lonotropic Glutamate Receptor Antagonist Production Market Share & Forecast by Region, 2018-2029

Figure 19. Lonotropic Glutamate Receptor Antagonist Industry Chain

Figure 20. Lonotropic Glutamate Receptor Antagonist Procurement Model

Figure 21. Lonotropic Glutamate Receptor Antagonist Sales Model

Figure 22. Lonotropic Glutamate Receptor Antagonist Sales Channels, Direct Sales and Distribution

Figure 23. N-Methyl-D-Aspartate Receptors

Figure 24. Marine Human Alginate Receptors

Figure 25. α-Amino-3 Hydroxy-5 Methyl-4 Isoxazole Receptors

Figure 26. By Type, Global Lonotropic Glutamate Receptor Antagonist Revenue, 2018-2029, US$ Million

Figure 27. By Type, Global Lonotropic Glutamate Receptor Antagonist Revenue Market Share, 2018-2029

Figure 28. By Type, Global Lonotropic Glutamate Receptor Antagonist Sales Volume, 2018-2029, (Units)

Figure 29. By Type, Global Lonotropic Glutamate Receptor Antagonist Sales Volume Market Share, 2018-2029

Figure 30. By Type, Global Lonotropic Glutamate Receptor Antagonist Price, 2018-2029, (US$/Unit)

Figure 31. Hospitals

Figure 32. Clinics

Figure 33. Research Institutes

Figure 34. Others

Figure 35. By Application, Global Lonotropic Glutamate Receptor Antagonist Revenue, 2018-2029, US$ Million

Figure 36. By Application, Global Lonotropic Glutamate Receptor Antagonist Revenue Market Share, 2018-2029

Figure 37. By Application, Global Lonotropic Glutamate Receptor Antagonist Sales Volume, 2018-2029, (Units)

Figure 38. By Application, Global Lonotropic Glutamate Receptor Antagonist Sales Volume Market Share, 2018-2029

Figure 39. By Application, Global Lonotropic Glutamate Receptor Antagonist Price, 2018-2029, (US$/Unit)

Figure 40. By Region, Global Lonotropic Glutamate Receptor Antagonist Revenue Market Share, 2018-2029

Figure 41. By Region, Global Lonotropic Glutamate Receptor Antagonist Sales Volume Market Share, 2018-2029

Figure 42. North America Lonotropic Glutamate Receptor Antagonist Revenue & Forecasts, 2018-2029, US$ Million

Figure 43. By Country, North America Lonotropic Glutamate Receptor Antagonist Revenue Market Share, 2022

Figure 44. Europe Lonotropic Glutamate Receptor Antagonist Revenue & Forecasts, 2018-2029, US$ Million

Figure 45. By Country, Europe Lonotropic Glutamate Receptor Antagonist Revenue Market Share, 2022

Figure 46. Asia Pacific Lonotropic Glutamate Receptor Antagonist Revenue & Forecasts, 2018-2029, US$ Million

Figure 47. By Country/Region, Asia Pacific Lonotropic Glutamate Receptor Antagonist Revenue Market Share, 2022

Figure 48. South America Lonotropic Glutamate Receptor Antagonist Revenue & Forecasts, 2018-2029, US$ Million

Figure 49. By Country, South America Lonotropic Glutamate Receptor Antagonist Revenue Market Share, 2022

Figure 50. Middle East & Africa Lonotropic Glutamate Receptor Antagonist Revenue & Forecasts, 2018-2029, US$ Million

Figure 51. U.S. Lonotropic Glutamate Receptor Antagonist Sales Volume, 2018-2029, (Units)

Figure 52. By Company, U.S. Lonotropic Glutamate Receptor Antagonist Market Share, 2022

Figure 53. By Type, U.S. Lonotropic Glutamate Receptor Antagonist Sales Volume Market Share, 2022 VS 2029

Figure 54. By Application, U.S. Lonotropic Glutamate Receptor Antagonist Sales Volume Market Share, 2022 VS 2029

Figure 55. Europe Lonotropic Glutamate Receptor Antagonist Sales Volume, 2018-2029, (Units)

Figure 56. By Company, Europe Lonotropic Glutamate Receptor Antagonist Market Share, 2022

Figure 57. By Type, Europe Lonotropic Glutamate Receptor Antagonist Sales Volume Market Share, 2022 VS 2029

Figure 58. By Application, Europe Lonotropic Glutamate Receptor Antagonist Sales Volume Market Share, 2022 VS 2029

Figure 59. China Lonotropic Glutamate Receptor Antagonist Sales Volume, 2018-2029, (Units)

Figure 60. By Company, China Lonotropic Glutamate Receptor Antagonist Market Share, 2022

Figure 61. By Type, China Lonotropic Glutamate Receptor Antagonist Sales Volume Market Share, 2022 VS 2029

Figure 62. By Application, China Lonotropic Glutamate Receptor Antagonist Sales Volume Market Share, 2022 VS 2029

Figure 63. Japan Lonotropic Glutamate Receptor Antagonist Sales Volume, 2018-2029, (Units)

Figure 64. By Company, Japan Lonotropic Glutamate Receptor Antagonist Market Share, 2022

Figure 65. By Type, Japan Lonotropic Glutamate Receptor Antagonist Sales Volume Market Share, 2022 VS 2029

Figure 66. By Application, Japan Lonotropic Glutamate Receptor Antagonist Sales Volume Market Share, 2022 VS 2029

Figure 67. South Korea Lonotropic Glutamate Receptor Antagonist Sales Volume, 2018-2029, (Units)

Figure 68. By Company, South Korea Lonotropic Glutamate Receptor Antagonist Market Share, 2022

Figure 69. By Type, South Korea Lonotropic Glutamate Receptor Antagonist Sales Volume Market Share, 2022 VS 2029

Figure 70. By Application, South Korea Lonotropic Glutamate Receptor Antagonist Sales Volume Market Share, 2022 VS 2029

Figure 71. Southeast Asia Lonotropic Glutamate Receptor Antagonist Sales Volume, 2018-2029, (Units)

Figure 72. By Company, Southeast Asia Lonotropic Glutamate Receptor Antagonist Market Share, 2022

Figure 73. By Type, Southeast Asia Lonotropic Glutamate Receptor Antagonist Sales Volume Market Share, 2022 VS 2029

Figure 74. By Application, Southeast Asia Lonotropic Glutamate Receptor Antagonist Sales Volume Market Share, 2022 VS 2029

Figure 75. India Lonotropic Glutamate Receptor Antagonist Sales Volume, 2018-2029, (Units)

Figure 76. By Company, India Lonotropic Glutamate Receptor Antagonist Market Share, 2022

Figure 77. By Type, India Lonotropic Glutamate Receptor Antagonist Sales Volume Market Share, 2022 VS 2029

Figure 78. By Application, India Lonotropic Glutamate Receptor Antagonist Sales Volume Market Share, 2022 VS 2029

Figure 79. Middle East & Asia Lonotropic Glutamate Receptor Antagonist Sales Volume, 2018-2029, (Units)

Figure 80. By Company, Middle East & Asia Lonotropic Glutamate Receptor Antagonist Market Share, 2022

Figure 81. By Type, Middle East & Asia Lonotropic Glutamate Receptor Antagonist Sales Volume Market Share, 2022 VS 2029

Figure 82. By Application, Middle East & Asia Lonotropic Glutamate Receptor Antagonist Sales Volume Market Share, 2022 VS 2029

Figure 83. Research Methodology

Figure 84. Breakdown of Primary Interviews

Figure 85. Bottom-up Approaches

Figure 86. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)